Sample Name
Sample Code
Sample Name
Sample Code
Sample Name
Sample Code
4
JD HEALTH
06618
5
ALI HEALTH
00241
| (Q3)Sep 30, 2025 | (Q2)Jun 30, 2025 | (Q1)Mar 31, 2025 | (FY)Dec 31, 2024 | (Q4)Dec 31, 2024 | (Q3)Sep 30, 2024 | (Q2)Jun 30, 2024 | (Q1)Mar 31, 2024 | (FY)Dec 31, 2023 | (Q4)Dec 31, 2023 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow (Indirect Method) | ||||||||||
| Cash flow from continuing operating activities | 108.49%7.86M | -51.51%1.19M | 152.89%1.66M | 11.47%11.02M | 423.92%4.14M | -21.55%3.77M | -23.01%2.45M | -40.40%658K | 59.71%9.89M | -60.93%790K |
| Net income from continuing operations | -57.74%131K | -67.35%460K | 232.34%622K | -38.57%1.63M | 144.19%380K | 7.64%310K | -43.00%1.41M | -162.50%-470K | -55.79%2.65M | -127.96%-860K |
| Operating gains losses | -107.72%-22K | 219.23%93K | -183.61%-51K | 783.33%954K | 306.51%687K | 3,462.50%285K | -13.04%-78K | --61K | 170.59%108K | 776.00%169K |
| Depreciation and amortization | 99.94%3.56M | 81.59%3.05M | 50.97%2.42M | 46.19%7.11M | 42.66%2.05M | 36.09%1.78M | 49.02%1.68M | 61.39%1.6M | 45.16%4.86M | 51.90%1.44M |
| Remuneration paid in stock | 159.48%1.4M | 211.70%879K | 169.77%580K | 178.65%1.57M | 195.00%531K | 126.05%538K | 213.33%282K | 298.15%215K | 335.66%562K | 291.30%180K |
| Other non cashItems | 20.67%181K | -39.25%195K | -15.22%156K | -9.00%617K | -114.90%-38K | -0.66%150K | 163.11%321K | 22.67%184K | 15.70%678K | 96.15%255K |
| Change In working capital | 269.63%2.62M | -200.43%-3.49M | -120.79%-2.06M | -183.58%-855K | 235.29%529K | -74.84%708K | -108.63%-1.16M | -10.55%-933K | 156.74%1.02M | -167.81%-391K |
| -Change in receivables | ---- | ---- | ---- | -738.49%-3.72M | ---- | ---- | ---- | ---- | 137.40%582K | ---- |
| -Change in inventory | ---- | ---- | ---- | -99.17%7K | ---- | ---- | ---- | ---- | 190.13%840K | ---- |
| -Change in prepaid assets | ---- | ---- | ---- | 19.40%-187K | ---- | ---- | ---- | ---- | -7.41%-232K | ---- |
| -Change in payables and accrued expense | ---- | ---- | ---- | 9,044.12%3.04M | ---- | ---- | ---- | ---- | -104.40%-34K | ---- |
| -Change in other working capital | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | -203.91%-133K | ---- |
| Tax refund paid | ---- | ---- | ---- | ---- | ---- | --0 | --0 | --0 | ---- | ---- |
| Cash from discontinued investing activities | ||||||||||
| Operating cash flow | 108.49%7.86M | -51.51%1.19M | 152.89%1.66M | 11.47%11.02M | 423.92%4.14M | -21.55%3.77M | -23.01%2.45M | -40.40%658K | 59.71%9.89M | -60.93%790K |
| Investing cash flow | ||||||||||
| Cash flow from continuing investing activities | -212.50%-17.45M | -143.61%-13.7M | -352.80%-9.07M | -52.65%-20.53M | -223.30%-7.33M | -45.92%-5.58M | 2.00%-5.62M | -23.43%-2M | -56.28%-13.45M | -38.68%-2.27M |
| Net PPE purchase and sale | -220.94%-17.41M | -140.04%-14.5M | -364.97%-11.29M | -60.56%-21.38M | -191.06%-7.49M | -78.25%-5.42M | -3.25%-6.04M | -31.37%-2.43M | -51.98%-13.32M | -53.89%-2.57M |
| Net other investing changes | 75.47%-39K | 92.14%807K | 422.01%2.23M | 739.85%851K | -46.91%163K | 79.69%-159K | 265.22%420K | 88.11%427K | -185.26%-133K | 707.89%307K |
| Cash from discontinued investing activities | ||||||||||
| Investing cash flow | -212.50%-17.45M | -143.61%-13.7M | -352.80%-9.07M | -52.65%-20.53M | -223.30%-7.33M | -45.92%-5.58M | 2.00%-5.62M | -23.43%-2M | -56.28%-13.45M | -38.68%-2.27M |
| Financing cash flow | ||||||||||
| Cash flow from continuing financing activities | 349.65%4.69M | -113.70%-1.49M | 1,576.18%22.03M | 208.91%13.8M | 77.22%3.53M | -48.54%-1.88M | 205.49%10.84M | 573.85%1.31M | 55.14%4.47M | 309.59%1.99M |
| Net issuance payments of debt | 360.77%4.61M | 66.51%-1.62M | -245.41%-1.59M | -149.40%-1.99M | 80.75%3.51M | -39.84%-1.77M | -241.85%-4.82M | 2,280.00%1.09M | 335.93%4.03M | 304.74%1.94M |
| Net common stock issuance | 59.66%-71K | -100.09%-12K | --23.58M | --13.41M | --4K | ---176K | --13.59M | --0 | --0 | --0 |
| Proceeds from stock option exercised by employees | 125.76%149K | -93.17%142K | -84.82%34K | 440.68%2.38M | -80.43%9K | --66K | 1,295.97%2.08M | -8.57%224K | 3,900.00%440K | --46K |
| Cash from discontinued financing activities | ||||||||||
| Financing cash flow | 349.65%4.69M | -113.70%-1.49M | 1,576.18%22.03M | 208.91%13.8M | 77.22%3.53M | -48.54%-1.88M | 205.49%10.84M | 573.85%1.31M | 55.14%4.47M | 309.59%1.99M |
| Net cash flow | ||||||||||
| Beginning cash position | -29.85%6.4M | 1,311.84%20.39M | 290.98%5.76M | 158.14%1.47M | 464.52%5.43M | 632.21%9.12M | 482.26%1.44M | 158.14%1.47M | 428.70%571K | -15.11%961K |
| Current changes in cash | -32.59%-4.89M | -282.38%-13.99M | 48,846.67%14.62M | 374.97%4.29M | -34.11%338K | -1,199.65%-3.69M | 669.51%7.67M | 90.71%-30K | 95.03%903K | 191.44%513K |
| End cash Position | -72.33%1.5M | -29.85%6.4M | 1,311.84%20.39M | 290.98%5.76M | 290.98%5.76M | 464.52%5.43M | 632.21%9.12M | 482.26%1.44M | 158.14%1.47M | 158.14%1.47M |
| Free cash from | -477.50%-9.55M | -270.86%-13.31M | -443.76%-9.63M | -189.77%-10.37M | -84.76%-3.36M | -194.95%-1.65M | -30.17%-3.59M | -137.72%-1.77M | -27.91%-3.58M | -671.38%-1.82M |
| Accounting Standards | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP |
| Audit Opinions | -- | -- | -- | Unqualified Opinion | -- | -- | -- | -- | Unqualified Opinion | -- |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.